Does Medicare Cover Diabetic Neuropathy Treatment? Drugs, PT, and 2026 Costs

Yes - Medicare covers diabetic neuropathy treatment across multiple programs: nerve conduction studies under Part B, FDA-approved medications under Part D, physical therapy under Part B, and a specific foot care exception that makes routine podiatry visits a covered benefit for people with documented diabetic peripheral neuropathy. Therapeutic shoes, TENS units, and ankle-foot orthotics are also covered as durable medical equipment.

Diabetic neuropathy is the most common complication of diabetes and one of the most common reasons Medicare beneficiaries seek specialist care. Roughly 27 percent of Medicare beneficiaries have diabetes, and approximately half of those with long-standing diabetes develop some form of neuropathy. That adds up to more than six million Medicare patients dealing with nerve damage - burning feet, numbness, balance problems, or autonomic dysfunction - who need to understand what their coverage pays for.

This guide covers every Medicare-covered treatment for diabetic neuropathy, the costs you should expect in 2026, and the specific coverage rules that determine what you owe.

What Is Diabetic Neuropathy?

Diabetic neuropathy is nerve damage caused by chronically elevated blood glucose. High blood sugar damages the small blood vessels that supply nerve fibers, starving them of oxygen and nutrients over years or decades. The nerve damage is irreversible once it occurs; treatment focuses on slowing progression through glycemic control and managing symptoms.

There are four main types:

  • Peripheral neuropathy - the most common type, affecting feet and legs first (then hands and arms in advanced cases). Symptoms include burning, tingling, numbness, shooting pain, and loss of protective sensation. The loss of sensation is the most dangerous feature because foot injuries go undetected and progress to ulcers and amputation.
  • Autonomic neuropathy - damage to nerves controlling the heart, blood vessels, digestive system, and bladder. Can cause postural hypotension (dizziness on standing), gastroparesis (slow gastric emptying), bladder dysfunction, and sexual dysfunction.
  • Proximal neuropathy (diabetic amyotrophy) - affects the hip, thigh, or buttock on one side, causing severe pain followed by muscle weakness. Less common, often improving over months.
  • Focal mononeuropathy - sudden weakness of a specific nerve (most often the third cranial nerve, causing eye movement problems, or the ulnar or peroneal nerves). Usually improves on its own.

Most Medicare coverage for diabetic neuropathy is focused on peripheral neuropathy, which is by far the most prevalent and clinically significant form.

Medicare Coverage at a Glance

ServiceMedicare Part2026 Out-of-Pocket
Nerve conduction study / EMGPart B20% after $257 deductible
Annual foot exam (documented DPN)Part B20% after $257 deductible
Routine foot care with LOPSPart B20% after $257 deductible
Physical therapyPart B20% after $257 deductible
Gabapentin (generic)Part D$0-$10/month (Tier 1)
Duloxetine generic (Cymbalta)Part D$5-$25/month (Tier 1-2)
Pregabalin generic (Lyrica)Part D$10-$50/month (Tier 2-3)
Therapeutic shoes and insertsPart B DME20% after $257 deductible
TENS unitPart B DME20% after $257 deductible
Ankle-foot orthosis (AFO)Part B DME20% after $257 deductible

Diagnosing Diabetic Neuropathy: What Medicare Covers

Medicare Part B covers the diagnostic workup for diabetic neuropathy when ordered by a treating physician.

Nerve conduction studies (NCS) and electromyography (EMG): These are the gold-standard tests for confirming and characterizing peripheral neuropathy. NCS measures how quickly electrical signals travel through specific nerves - slowed conduction velocity confirms nerve damage. EMG measures electrical activity in muscles and helps distinguish nerve damage from muscle disease. Both are covered under Part B when medically necessary, subject to the standard 20% coinsurance after the Part B deductible ($257 in 2026).

Annual diabetic foot exam: Medicare covers one comprehensive foot exam per year for people with diabetes who do not have an open sore or infection. The exam checks for signs of peripheral neuropathy, poor circulation, and foot deformities. No coinsurance applies if performed by a qualified physician in an appropriate setting and billed as a preventive service.

Neurological consultation: If your primary care physician refers you to a neurologist for evaluation of neuropathy, the specialist visit is covered under Part B at the standard 20% coinsurance rate.

Lab work: HbA1c tests, complete metabolic panels, and thyroid panels used to evaluate neuropathy causes are covered under Part B when ordered by your treating physician.

Prescription Drug Coverage: Part D

The FDA has approved several medications specifically for diabetic peripheral neuropathy, and many more are used off-label for neuropathic pain. All fall under Medicare Part D prescription drug coverage. Coverage specifics vary by plan - check your plan’s formulary using the Medicare Plan Finder at Medicare.gov before assuming a drug is covered.

FDA-Approved First-Line Drugs

Pregabalin (Lyrica): The first FDA-approved medication for diabetic peripheral neuropathy. Brand Lyrica is typically Tier 3-4 on most Part D formularies. Generic pregabalin (available since 2019) is usually Tier 2 and significantly cheaper. Generic pregabalin commonly costs $10-$50 per month on Medicare Part D plans. Pregabalin is a Schedule V controlled substance, which means some plans require prior authorization or step therapy (requiring a trial of gabapentin first).

Duloxetine (Cymbalta): Also FDA-approved for DPN and widely considered a first-line option. Generic duloxetine is available and typically falls in Tier 1 or Tier 2 on most formularies, costing $5-$25 per month. Duloxetine also treats depression and generalized anxiety, making it a natural choice for patients with these comorbidities.

Tapentadol extended-release (Nucynta ER): FDA-approved for DPN pain management in patients who need around-the-clock opioid treatment and for whom alternative treatments are inadequate. As an opioid, it carries strict formulary controls - prior authorization, quantity limits, and step therapy requirements are common. Use is typically reserved for patients who have failed multiple non-opioid approaches.

Widely Used Off-Label Drugs

Gabapentin (Neurontin): Though only FDA-approved for postherpetic neuralgia (not DPN specifically), gabapentin is one of the most commonly prescribed drugs for diabetic neuropathic pain and is a standard of care in clinical practice. Generic gabapentin is Tier 1 on most Part D formularies and very inexpensive - often $0-$10 per month. Many plans require a trial of gabapentin before they will approve pregabalin.

Tricyclic antidepressants (amitriptyline, nortriptyline, desipramine): Generic tricyclics are Tier 1 on virtually all Part D formularies and cost $1-$5 per month. They are particularly useful in patients who have both neuropathic pain and sleep disruption. The anticholinergic side effects (dry mouth, constipation, urinary retention) limit use in elderly patients but many people tolerate them well at low doses (10-50 mg at bedtime, far below antidepressant doses).

Topical capsaicin: Available as over-the-counter cream (not covered by Part D) and as a high-concentration 8% patch (Qutenza) applied in a clinical setting every 3 months. The Qutenza patch is administered by a healthcare provider and may be billed under Part B rather than Part D. It depletes substance P at nerve endings and can provide meaningful pain relief with minimal systemic side effects.

Lidocaine patches (Lidoderm): Generic lidocaine patches are covered under Part D and provide localized topical anesthesia. Useful for focal areas of allodynia (pain to light touch).

Low-Income Subsidy and Part D Extra Help

If you qualify for Part D Extra Help (also called Low Income Subsidy), your copays for Part D drugs are dramatically reduced - often $1-$10 per drug per month regardless of tier. DPN typically requires chronic daily medication, so Extra Help can represent thousands of dollars in annual savings. Apply through the Social Security Administration at SSA.gov.

Physical Therapy: Part B Coverage

Physical therapy for diabetic neuropathy is covered under Medicare Part B when prescribed by a physician and provided by a qualified physical therapist in an approved setting.

PT for diabetic neuropathy typically targets:

  • Balance and fall prevention: Peripheral neuropathy significantly increases fall risk. PT balance training with proprioception exercises is one of the most evidence-supported non-pharmacological interventions.
  • Gait training: Neuropathy-related foot drop or altered gait patterns are addressed with targeted exercises and gait retraining.
  • Strengthening: Lower extremity strengthening to compensate for sensory deficits.
  • Desensitization and sensory re-education: Gradual exposure to sensory stimuli to improve how the nervous system processes sensation.

Medicare Part B covers outpatient PT with no hard annual visit cap. Once cumulative annual therapy charges for PT, occupational therapy, and speech therapy combined exceed $2,480, the KX modifier must be added to claims to confirm ongoing medical necessity - this allows unlimited additional visits. Prior authorization is required for some Medicare Advantage plans once the threshold is crossed.

The standard Part B cost-sharing applies: 20% coinsurance after the $257 annual Part B deductible. With Medigap Plan G, the Part B deductible is covered after a one-time annual out-of-pocket payment, then no coinsurance for the rest of the year.

For full details on Medicare PT rules and costs, see the Medicare physical therapy coverage guide.

Podiatry and Foot Care: The Neuropathy Exception

This is one of the most important coverage rules for diabetic neuropathy patients: Medicare Part B covers routine foot care - nail trimming, callus removal, corns, skin inspection - for people with documented diabetic peripheral neuropathy with loss of protective sensation (LOPS).

Normally, Medicare does not cover routine podiatry. Nail trimming alone is not a covered service. But diabetic peripheral neuropathy creates a specific statutory exception because foot injuries that go undetected due to sensory loss lead to ulcers, infections, and amputations - outcomes that are far more expensive to treat and devastating to quality of life.

To qualify for covered routine foot care under the neuropathy exception:

  1. You have a diabetes diagnosis documented in your medical record
  2. Your physician or podiatrist has documented diabetic peripheral neuropathy with loss of protective sensation (LOPS) in the clinical record
  3. The foot care is provided by a qualified podiatrist or physician

Coverage applies to periodic visits - typically every 6-8 weeks for high-risk patients. Medicare Part B pays 80% after the deductible; you pay 20% coinsurance.

Annual comprehensive foot exam: Medicare also covers one annual foot exam for people with diabetes who do not have an active foot problem. The exam checks nerve function, circulation, and structure.

For the full podiatry coverage rules including the Class Finding system and covered foot surgeries, see the Medicare podiatry and foot care coverage guide.

Therapeutic Shoes and Inserts: Part B DME

Medicare Part B provides a specific benefit for diabetic patients with certain foot complications: one pair of therapeutic shoes per calendar year, plus three pairs of inserts.

Who qualifies: You must have diabetes AND at least one of the following foot conditions:

  • History of diabetic foot ulceration
  • History of partial or complete foot amputation
  • Pre-ulcerative calluses
  • Peripheral neuropathy with signs of callous formation
  • Foot deformity
  • Poor circulation (peripheral arterial disease)

Types of shoes covered: Extra-depth shoes (designed to accommodate deformities and orthotics without pressure points) or custom-molded shoes (for patients with severe deformities that cannot be accommodated by off-the-shelf extra-depth shoes).

Cost: Medicare pays 80% of the approved amount after the Part B deductible. The approved amount is set by Medicare nationally. Custom-molded shoes cost more but Medicare’s payment is proportionally higher. You pay 20% coinsurance plus any difference if the supplier charges above the Medicare-approved amount.

Prescription requirement: Your treating physician (not the podiatrist or orthotist) must certify that therapeutic shoes are medically necessary. The shoes must be fitted and provided by a qualified podiatrist, orthotist, or pedorthist.

Durable Medical Equipment: TENS Units and Orthotics

TENS units (Transcutaneous Electrical Nerve Stimulation): Medicare Part B covers TENS units for the treatment of chronic intractable pain as durable medical equipment. Diabetic neuropathic pain may qualify, but Medicare’s coverage criteria require documentation that the pain is chronic, intractable (not responding to other treatments), and that TENS has been tried and shown to provide at least partial relief during a trial period. A physician must prescribe the TENS unit from a Medicare-enrolled DME supplier.

Ankle-foot orthotics (AFOs): For patients with foot drop (peroneal nerve palsy from focal mononeuropathy or severe peripheral neuropathy), Medicare Part B covers an ankle-foot orthosis as DME. The AFO must be prescribed by a physician and obtained from a Medicare-enrolled orthotist. Coverage applies to both rigid and articulated AFOs.

Custom foot orthotics: Custom-molded foot orthotics (beyond the therapeutic shoe inserts described above) are generally not covered by Part B for non-diabetic patients. For diabetic patients meeting the therapeutic shoe benefit criteria, the inserts are covered as part of that benefit.

What Medicare Does NOT Cover for Diabetic Neuropathy

Understanding the exclusions prevents surprise bills:

  • Alpha-lipoic acid supplements: Popular in some countries as a neuropathy treatment, but dietary supplements are not covered by Medicare Part D regardless of evidence.
  • Massage therapy alone: Medicare does not cover massage as a standalone treatment. If massage is part of a physical therapy session delivered by a qualified PT, the PT visit is covered, but massage billed separately is not.
  • Acupuncture for neuropathy: Medicare covers acupuncture only for chronic low back pain. Acupuncture for diabetic neuropathy is not covered.
  • Experimental or investigational treatments: Any treatment not recognized as standard of care may be denied as experimental.
  • Over-the-counter capsaicin cream: Available without a prescription but not covered by Part D (the high-concentration 8% Qutenza patch, applied clinically, is a different product and may be covered under Part B).
  • Dietary counseling beyond covered visits: Intensive dietary counseling that exceeds Medicare’s covered medical nutrition therapy sessions is not covered.

Medicare Advantage Considerations

Medicare Advantage plans (Part C) must cover all Medicare-required benefits for diabetic neuropathy but may add prior authorization requirements that original Medicare does not impose. Watch for:

  • Prior authorization for pregabalin: Many Advantage plans require step therapy - documenting a trial of gabapentin before they approve pregabalin. Build 60-90 days into your planning when starting treatment.
  • Network restrictions for podiatry and neurology: Advantage plans use provider networks. Confirm your podiatrist, neurologist, and physical therapist are in-network before booking.
  • Formulary differences: Part D drug formularies on Advantage plans vary. The plan’s formulary is published annually - check it for your specific medications using the Medicare Plan Finder.
  • Physical therapy prior authorization: Some Advantage plans require pre-approval for physical therapy beyond a certain number of visits per year.

If your Advantage plan denies a claim for diabetic neuropathy treatment, you have the right to appeal. Request a formal reconsideration within 60 days of the denial.

Medigap Plan G: Eliminating the 20% Coinsurance

If you have original Medicare plus a Medigap supplemental policy, your out-of-pocket costs for diabetic neuropathy care drop substantially.

Plan G - the most comprehensive Medigap plan available to new enrollees - covers:

  • The Part B deductible ($257 in 2026) - you pay this once per year
  • All Part B coinsurance (20%) after the deductible - this is the biggest benefit for people with ongoing outpatient care
  • Part A deductible and coinsurance (relevant if hospitalization is needed)

For a diabetic neuropathy patient with regular podiatry visits, physical therapy, and specialist care, Plan G can easily save $500-$2,000 per year compared to original Medicare alone. The monthly premium (varies by age, state, and insurer but typically $100-$200/month) must be weighed against expected savings.

Medicare Savings Programs for Low-Income Beneficiaries

If your income is limited, four Medicare Savings Programs can help pay Medicare premiums and cost-sharing:

ProgramIncome Limit (individual)What It Pays
QMB138% FPL ($20,120/yr)Part A and B premiums, deductibles, and coinsurance
SLMB150% FPL ($21,870/yr)Part B premium only
QI185% FPL ($26,973/yr)Part B premium only
QDWI~200% FPLPart A premium for certain beneficiaries

Income limits above are approximate 2026 figures and vary by state. QMB is the most valuable: once enrolled, Medicare providers cannot charge QMB beneficiaries any copays or coinsurance on covered services. Apply through your state Medicaid agency.

Also apply for Part D Extra Help through SSA.gov to reduce medication costs.

2026 Costs for Common Diabetic Neuropathy Services

ServiceMedicare PaysYour Share (without Medigap)Your Share (with Plan G)
Nerve conduction study / EMG80%$60-$120 (20% coinsurance)$0 after deductible
Podiatry visit (DPN documented)80%$20-$40 (20% coinsurance)$0 after deductible
Physical therapy session80%$20-$50 (20% coinsurance)$0 after deductible
Therapeutic shoes80%20% of approved amount (~$30-$80)$0 after deductible
TENS unit (purchase)80%20% (~$30-$60)$0 after deductible
Gabapentin (generic, Part D)Plan-dependent$0-$10/month (Tier 1)Same (Part D not affected by Medigap)
Duloxetine (generic, Part D)Plan-dependent$5-$25/month (Tier 1-2)Same
Pregabalin (generic, Part D)Plan-dependent$10-$50/month (Tier 2-3)Same

The Part B annual deductible is $257 in 2026. Once met, the 20% coinsurance applies to all further Part B services for the year. Part D costs are plan-specific and unaffected by Medigap supplemental policies.

5-Step Guide to Maximizing Your Diabetic Neuropathy Coverage

Step 1 - Get the diagnosis documented correctly. Your physician must document “diabetic peripheral neuropathy with loss of protective sensation” in your medical record - not just “diabetes” or “neuropathy.” This specific phrasing unlocks the Medicare foot care exception and other coverage pathways. If your records just say “numbness in feet,” ask your doctor to update the documentation.

Step 2 - Confirm your drug formulary before starting treatment. Neuropathy medications vary significantly in cost across Part D plans. Check your current plan’s formulary at Medicare.gov. If you are starting treatment for the first time or during open enrollment (Oct 15 - Dec 7), compare plans using the Plan Finder - filter for your specific medications.

Step 3 - Ask about step therapy timelines. If your physician wants to prescribe pregabalin directly, ask whether your Part D plan or Medicare Advantage plan requires a trial of gabapentin first. If yes, start gabapentin early to satisfy the step therapy requirement before requesting pregabalin if gabapentin is insufficient.

Step 4 - Use your annual foot exam. Even if you have no foot pain, the annual diabetic foot exam is a covered preventive service. Use it to have baseline nerve function documented, establish the LOPS finding if present, and catch early changes before they become ulcers.

Step 5 - Apply for Medicare Savings Programs and Part D Extra Help if your income is limited. A QMB enrollment eliminates all Part B cost-sharing - which can be very significant for someone with regular podiatry visits, PT sessions, and neurological care. Apply through your state Medicaid office and SSA.gov.

Frequently Asked Questions

Does Medicare cover gabapentin for diabetic neuropathy?

Yes. Generic gabapentin is covered under Medicare Part D and is typically Tier 1 on most formularies, costing $0-$10 per month. While gabapentin is technically FDA-approved only for postherpetic neuralgia, its use for diabetic neuropathic pain is standard of care and covered by Part D as a medically accepted indication.

Does Medicare cover Lyrica (pregabalin) for neuropathy?

Yes. Pregabalin (brand Lyrica, now available as generic) is FDA-approved for diabetic peripheral neuropathy and is covered under Part D. Generic pregabalin is significantly cheaper than brand Lyrica. Some plans require step therapy - a trial of gabapentin first - before approving pregabalin. Check your plan’s formulary and prior authorization requirements.

Does Medicare cover routine foot care if I have diabetic neuropathy?

Yes, with documentation. Medicare Part B covers routine foot care (nail trimming, callus removal, skin inspection) for Medicare beneficiaries with documented diabetic peripheral neuropathy with loss of protective sensation. Your podiatrist must document the neuropathy diagnosis in the visit notes. Without this documentation, routine foot care is not covered.

Are therapeutic shoes covered by Medicare?

Yes, for qualifying diabetic patients. Medicare Part B covers one pair of extra-depth or custom-molded shoes plus three pairs of inserts per calendar year for people with diabetes who have at least one qualifying foot condition (neuropathy with callous formation, prior ulceration, amputation, deformity, or poor circulation). Your treating physician must certify medical necessity.

Does Medicare cover physical therapy for diabetic neuropathy?

Yes. Physical therapy for diabetic neuropathy - including balance training, gait training, and fall prevention - is covered under Part B when prescribed by a physician and medically necessary. There is no hard annual cap on PT visits. The 20% coinsurance applies after the annual deductible.

Does Medicare cover a TENS unit for neuropathy pain?

Possibly. Medicare Part B covers TENS units as DME for chronic intractable pain, and neuropathic pain may qualify. Coverage requires documentation that the pain is chronic and not responding to other treatments, and that a trial of TENS has demonstrated benefit. Your physician prescribes it and you must use a Medicare-enrolled DME supplier.

Does Medicare cover nerve conduction studies (NCS/EMG) for neuropathy diagnosis?

Yes. Nerve conduction studies and electromyography are covered under Medicare Part B when ordered by a treating physician to diagnose or evaluate peripheral neuropathy. The standard 20% coinsurance applies after the Part B deductible.

Can Medicare Advantage deny treatment for diabetic neuropathy?

Advantage plans can require prior authorization before approving certain services, and can deny requests that do not meet their coverage criteria. However, they cannot deny coverage for services that original Medicare covers. If your plan denies a service, you have the right to appeal within 60 days of the denial notice. You can also request an expedited appeal (72-hour response) if your health requires urgent treatment.

Sources